Skip to main content
To the Editor: We thank Dr. Pearson Murphy for her comments on our recent article on neuroactive steroids in patients with panic disorder before and during paroxetine treatment. Because our article was published as a Brief Report, we had to be as brief as possible with regard to the description of our methods. Two of the seven women in both groups were postmenopausal. We agree that the reported progesterone levels of about 20 nmol/liter are too high for this study group, and we therefore have reanalyzed our gas chromatography/mass spectrometry data. In doing so, we found that when switching from steroid analysis by gas chromatography/mass spectrometry from the electron impact mode that was employed in our previous study of depression (1998) to the negative chemical ionization mode, we made a mistake with the calculation of progesterone concentrations. In our article, we reported on calculations based on m/z 178 and m/z 197, which represent both progesterone and pregnenolone (which partially coelute), instead of m/z 197, which represents progesterone only. This explains why the progesterone values reported were too high. We now have recalculated the progesterone levels using m/z 197. The corrected mean progesterone concentrations were 2.9 nmol/liter (SD=0.2) for the comparison subjects and 3.1 nmol/liter (SD=0.2) for the patients with panic disorder before paroxetine treatment. During paroxetine treatment of the patients with panic disorder, progesterone concentrations were between 2.6 nmol/liter (SD=0.2) and 2.9 nmol/liter (SD=0.3). The other steroid concentrations reported are correct. We seriously apologize for this error and thank Dr. Pearson Murphy for bringing up this issue, which enables us to provide the correct progesterone data. The slight differences between the correct progesterone data and those reported in our previous article regarding depression (1998) are probably due to the fact that in the meantime we changed both our gas chromatography/mass spectrometry instrument and our mode of steroid analysis.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 594
PubMed: 12611859

History

Published online: 1 March 2003
Published in print: March 2003

Authors

Affiliations

ANDREAS STRÖHLE, M.D.
FLAVIA di MICHELE, M.D.
ALEXANDER YASSOURIDIS, Ph.D.
FLORIAN HOLSBOER, M.D., Ph.D.
RAINER RUPPRECHT, M.D.
Munich, Germany

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share